tetano
Editor, Senior Moderator
Influenza Other Respir Viruses
. 2024 May;18(5):e13284.
doi: 10.1111/irv.13284. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
Heather Whitaker[SUP] 1 [/SUP], Beth Findlay[SUP] 2 [/SUP], Jana Zitha[SUP] 3 [/SUP], Rosalind Goudie[SUP] 4 [/SUP], Katie Hassell[SUP] 5 [/SUP], Josie Evans[SUP] 2 [/SUP], Panoraia Kalapotharakou[SUP] 3 [/SUP], Utkarsh Agrawal[SUP] 4 [/SUP], Beatrix Kele[SUP] 6 [/SUP], Mark Hamilton[SUP] 2 [/SUP], Catherine Moore[SUP] 7 [/SUP], Rachel Byford[SUP] 4 [/SUP], Julia Stowe[SUP] 5 [/SUP], Chris Robertson[SUP] 2 8 [/SUP], Anastasia Couzens[SUP] 7 [/SUP], Gavin Jamie[SUP] 4 [/SUP], Katja Hoschler[SUP] 6 [/SUP], Kathleen Pheasant[SUP] 7 [/SUP], Elizabeth Button[SUP] 4 [/SUP], Catherine Quinot[SUP] 5 [/SUP], Tim Jones[SUP] 7 [/SUP], Sneha Anand[SUP] 4 [/SUP], Conall Watson[SUP] 5 [/SUP], Nick Andrews[SUP] 5 [/SUP], Simon de Lusignan[SUP] 4 9 [/SUP], Maria Zambon[SUP] 6 [/SUP], Christopher Williams[SUP] 10 [/SUP], Simon Cottrell[SUP] 3 [/SUP], Kimberly Marsh[SUP] 2 [/SUP], Jim McMenamin[SUP] 2 [/SUP], Jamie Lopez Bernal[SUP] 5 [/SUP]
Affiliations
Background: We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital settings in Scotland and hospital settings in England.
Methods: A test negative design was used to estimate vaccine effectiveness.
Results: Estimated vaccine effectiveness against all influenzas ranged from 63% (95% confidence interval 46 to 75%) to 65% (41 to 79%) among children aged 2-17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18-64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.
Conclusions: During a period of co-circulation of influenza A(H1N1)pdm09 and A(H3N2) in the United Kingdom, evidence for effectiveness of the influenza vaccine in both children and adults was found.
Keywords: effectiveness; hospitalisation; influenza; vaccine.
. 2024 May;18(5):e13284.
doi: 10.1111/irv.13284. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
Heather Whitaker[SUP] 1 [/SUP], Beth Findlay[SUP] 2 [/SUP], Jana Zitha[SUP] 3 [/SUP], Rosalind Goudie[SUP] 4 [/SUP], Katie Hassell[SUP] 5 [/SUP], Josie Evans[SUP] 2 [/SUP], Panoraia Kalapotharakou[SUP] 3 [/SUP], Utkarsh Agrawal[SUP] 4 [/SUP], Beatrix Kele[SUP] 6 [/SUP], Mark Hamilton[SUP] 2 [/SUP], Catherine Moore[SUP] 7 [/SUP], Rachel Byford[SUP] 4 [/SUP], Julia Stowe[SUP] 5 [/SUP], Chris Robertson[SUP] 2 8 [/SUP], Anastasia Couzens[SUP] 7 [/SUP], Gavin Jamie[SUP] 4 [/SUP], Katja Hoschler[SUP] 6 [/SUP], Kathleen Pheasant[SUP] 7 [/SUP], Elizabeth Button[SUP] 4 [/SUP], Catherine Quinot[SUP] 5 [/SUP], Tim Jones[SUP] 7 [/SUP], Sneha Anand[SUP] 4 [/SUP], Conall Watson[SUP] 5 [/SUP], Nick Andrews[SUP] 5 [/SUP], Simon de Lusignan[SUP] 4 9 [/SUP], Maria Zambon[SUP] 6 [/SUP], Christopher Williams[SUP] 10 [/SUP], Simon Cottrell[SUP] 3 [/SUP], Kimberly Marsh[SUP] 2 [/SUP], Jim McMenamin[SUP] 2 [/SUP], Jamie Lopez Bernal[SUP] 5 [/SUP]
Affiliations
- PMID: 38773753
- PMCID: PMC11109477
- DOI: 10.1111/irv.13284
Background: We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital settings in Scotland and hospital settings in England.
Methods: A test negative design was used to estimate vaccine effectiveness.
Results: Estimated vaccine effectiveness against all influenzas ranged from 63% (95% confidence interval 46 to 75%) to 65% (41 to 79%) among children aged 2-17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18-64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.
Conclusions: During a period of co-circulation of influenza A(H1N1)pdm09 and A(H3N2) in the United Kingdom, evidence for effectiveness of the influenza vaccine in both children and adults was found.
Keywords: effectiveness; hospitalisation; influenza; vaccine.